Palladin is involved in platelet activation and arterial thrombosis

Thrombosis Research

Volumn 149, Issue , 2017, Pages 1-8

  Chen, Xuejiao ^a,c   Fan, Xuemei ^b   Tan, Juan ^a,c   Shi, Panlai ^b   Wang, Xiyi ^a,c   Wang, Jinjin ^c   Kuang, Ying ^c   Fei, Jian ^c   Liu, Junling ^b   Dang, Suying ^b,c   Wang, Zhugang ^a,c  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Shanghai Research Center for Model Organisms   (China)

Author keywords

Cdc42; Knockout mice; Paladin; Platelet activation; Rac1

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; COLLAGEN; FIBRINOGEN; HEMOGLOBIN; PALLADIN; PROTEIN; PROTEIN CDC42; RAC1 PROTEIN; THROMBIN; UNCLASSIFIED DRUG; CDC42 PROTEIN, MOUSE; CYTOSKELETON PROTEIN; NEUROPEPTIDE; PALLADIN PROTEIN, MOUSE; PHOSPHOPROTEIN; RAC1 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY THROMBOSIS; ARTICLE; BLEEDING TIME; BLOOD CELL COUNT; BLOOD CLOT RETRACTION; CONTROLLED STUDY; HEMOGLOBIN BLOOD LEVEL; HEMOSTASIS; HETEROZYGOTE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE RICH PLASMA; THROMBOCYTE VOLUME; ANIMAL; BLOOD; CYTOLOGY; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; THROMBOCYTE; THROMBOSIS;

ANIMALS; BLOOD PLATELETS; CDC42 GTP-BINDING PROTEIN; CYTOSKELETAL PROTEINS; HEMOSTASIS; HUMANS; MICE, KNOCKOUT; NEUROPEPTIDES; PHOSPHOPROTEINS; PLATELET ACTIVATION; PLATELET-RICH PLASMA; RAC1 GTP-BINDING PROTEIN; THROMBOSIS;

EID: 84995810975     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2016.11.010     Document Type: Article

References (31)

1. [1] Fox, J.E., Cytoskeletal proteins and platelet signaling. Thromb. Haemost. 86 (2001), 198–213.
2. [2] Otey, C.A., Rachlin, A., Moza, M., Arneman, D., Carpen, O., The palladin/myotilin/myopalladin family of actin-associated scaffolds. Int. Rev. Cytol. 246 (2005), 31–58.
3. [3] Boukhelifa, M., Parast, M.M., Valtschanoff, J.G., LaMantia, A.S., Meeker, R.B., et al. A role for the cytoskeleton-associated protein palladin in neurite outgrowth. Mol. Biol. Cell 12 (2001), 2721–2729.
4. [4] Hwang, S.J., Pagliardini, S., Boukhelifa, M., Parast, M.M., Otey, C.A., et al. Palladin is expressed preferentially in excitatory terminals in the rat central nervous system. J. Comp. Neurol. 436 (2001), 211–224.
5. [5] Boukhelifa, M., Hwang, S.J., Valtschanoff, J.G., Meeker, R.B., Rustioni, A., et al. A critical role for palladin in astrocyte morphology and response to injury. Mol. Cell. Neurosci. 23 (2003), 661–668.
6. [6] Mykkanen, O.M., Gronholm, M., Ronty, M., Lalowski, M., Salmikangas, P., et al. Characterization of human palladin, a microfilament-associated protein. Mol. Biol. Cell 12 (2001), 3060–3073.
7. [7] Parast, M.M., Otey, C.A., Characterization of palladin, a novel protein localized to stress fibers and cell adhesions. J. Cell Biol. 150 (2000), 643–656.
8. [8] Liu, X.S., Li, X.H., Wang, Y., Shu, R.Z., Wang, L., et al. Disruption of palladin leads to defects in definitive erythropoiesis by interfering with erythroblastic island formation in mouse fetal liver. Blood 110 (2007), 870–876.
9. [9] Luo, H., Liu, X., Wang, F., Huang, Q., Shen, S., et al. Disruption of palladin results in neural tube closure defects in mice. Mol. Cell. Neurosci. 29 (2005), 507–515.
10. [10] Liu, X.S., Luo, H.J., Yang, H., Wang, L., Kong, H., et al. Palladin regulates cell and extracellular matrix interaction through maintaining normal actin cytoskeleton architecture and stabilizing beta1-integrin. J. Cell. Biochem. 100 (2007), 1288–1300.
11. [11] Shiffman, D., Ellis, S.G., Rowland, C.M., Malloy, M.J., Luke, M.M., et al. Identification of four gene variants associated with myocardial infarction. Am. J. Hum. Genet. 77 (2005), 596–605.
12. [12] Lusis, A.J., Mar, R., Pajukanta, P., Genetics of atherosclerosis. Annu. Rev. Genomics Hum. Genet. 5 (2004), 189–218.
13. [13] George, J.N., Platelets. Lancet 355 (2000), 1531–1539.
14. [14] Leslie, M., Cell biology. Beyond clotting: the powers of platelets. Science 328 (2010), 562–564.
15. [15] Li, Z., Delaney, M.K., O'Brien, K.A., Du, X., Signaling during platelet adhesion and activation. Arterioscler. Thromb. Vasc. Biol. 30 (2010), 2341–2349.
16. [16] Aslan, J.E., McCarty, O.J., Rho GTPases in platelet function. J. Thromb. Haemost. 11:1 (2013), 35–46.
17. [17] Wang, H.V., Moser, M., Comparative expression analysis of the murine palladin isoforms. Dev. Dyn. 237 (2008), 3342–3351.
18. [18] Goicoechea, S.M., Bednarski, B., Stack, C., Cowan, D.W., Volmar, K., et al. Isoform-specific upregulation of palladin in human and murine pancreas tumors. PLoS One, 5, 2010, e10347.
19. [19] Marjanovic, J.A., Stojanovic, A., Brovkovych, V.M., Skidgel, R.A., Du, X., Signaling-mediated functional activation of inducible nitric-oxide synthase and its role in stimulating platelet activation. J. Biol. Chem. 283 (2008), 28827–28834.
20. [20] Lian, L., Suzuki, A., Hayes, V., Saha, S., Han, X., et al. Loss of ATE1-mediated arginylation leads to impaired platelet myosin phosphorylation, clot retraction, and in vivo thrombosis formation. Haematologica 99 (2014), 554–560.
21. [21] Yin, H., Liu, J., Li, Z., Berndt, M.C., Lowell, C.A., et al. Src family tyrosine kinase Lyn mediates VWF/GPIb-IX-induced platelet activation via the cGMP signaling pathway. Blood 112 (2008), 1139–1146.
22. [22] Flevaris, P., Li, Z., Zhang, G., Zheng, Y., Liu, J., et al. Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway. Blood 113 (2009), 893–901.
23. [23] Liu, J., Fitzgerald, M.E., Berndt, M.C., Jackson, C.W., Gartner, T.K., Bruton tyrosine kinase is essential for botrocetin/VWF-induced signaling and GPIb-dependent thrombus formation in vivo. Blood 108 (2006), 2596–2603.
24. [24] Weng, Z., Li, D., Zhang, L., Chen, J., Ruan, C., et al. PTEN regulates collagen-induced platelet activation. Blood 116 (2010), 2579–2581.
25. [25] Farrehi, P.M., Ozaki, C.K., Carmeliet, P., Fay, W.P., Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation 97 (1998), 1002–1008.
26. [26] Calaminus, S.D., Thomas, S., McCarty, O.J., Machesky, L.M., Watson, S.P., Identification of a novel, actin-rich structure, the actin nodule, in the early stages of platelet spreading. J. Thromb. Haemost. 6 (2008), 1944–1952.
27. [27] Goicoechea, S.M., Arneman, D., Otey, C.A., The role of palladin in actin organization and cell motility. Eur. J. Cell Biol. 87 (2008), 517–525.
28. [28] Dixon, R.D., Arneman, D.K., Rachlin, A.S., Sundaresan, N.R., Costello, M.J., et al. Palladin is an actin cross-linking protein that uses immunoglobulin-like domains to bind filamentous actin. J. Biol. Chem. 283 (2008), 6222–6231.
29. [29] Goicoechea, S., Arneman, D., Disanza, A., Garcia-Mata, R., Scita, G., et al. Palladin binds to Eps8 and enhances the formation of dorsal ruffles and podosomes in vascular smooth muscle cells. J. Cell Sci. 119 (2006), 3316–3324.
30. [30] Rachlin, A.S., Otey, C.A., Identification of palladin isoforms and characterization of an isoform-specific interaction between Lasp-1 and palladin. J. Cell Sci. 119 (2006), 995–1004.
31. [31] Fotinos, A., Klier, M., Gowert, N.S., Münzer, P., Klatt, C., et al. Loss of oligophrenin1 leads to uncontrolled Rho activation and increased thrombus formation in mice. J. Thromb. Haemost. 13:4 (2015), 619–630.